We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,768 results
  1. A comprehensive review on methotrexate containing nanoparticles; an appropriate tool for cancer treatment

    For more than seven decades, methotrexate has been used all over the world for treatment of different diseases such as: cancer, autoimmune diseases,...

    Hanifeh Shariatifar, Fateme Ranjbarian, ... Alireza Farasat in Molecular Biology Reports
    Article 12 September 2022
  2. Application of Cartilage Extracellular Matrix to Enhance Therapeutic Efficacy of Methotrexate

    BACKGROUND:

    Rheumatoid arthritis (RA) is characterized by chronic inflammation and joint damage. Methotrexate (MTX), a commonly used disease-modifying...

    Jeong-Woo Seo, Sung-Han Jo, ... Sang-Hyug Park in Tissue Engineering and Regenerative Medicine
    Article 14 October 2023
  3. Infliximab Ameliorates Methotrexate-Induced Nephrotoxicity in Experimental Rat Model: Impact on Oxidative Stress, Mitochondrial Biogenesis, Apoptotic and Autophagic Machineries

    Accumulating data confirms that Methotrexate (MTX), a well-known immunosuppressive and anticancer drug, causes nephrotoxicity. Infliximab (INF), the...

    Eman F. Wasfey, Marah Shaaban, ... Sara M. Radwan in Cell Biochemistry and Biophysics
    Article Open access 01 September 2023
  4. Possible ameliorative effect of human placental extract on methotrexate-induced nephrotoxicity in albino rats

    Background

    Methotrexate (MTX) is one of chemotherapeutic drugs that induce several side effects. The present study aimed to investigate the...

    Hoda A. Mahran, Yasser I. Khedr, ... Mohamed SA. El-Gerbed in The Journal of Basic and Applied Zoology
    Article Open access 16 July 2022
  5. Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways

    Background

    Organ toxicity limits the therapeutic efficacy of methotrexate (MTX), an anti-metabolite therapeutic that is frequently used as an...

    Hamit Emre Kızıl, Cuneyt Caglayan, ... Sefa Küçükler in Molecular Biology Reports
    Article 13 February 2023
  6. Characterization of 36-kDa Dimeric Methotrexate-degrading Enzyme from Variovorax paradoxus, its Performance and Stability of its Cross-linked Aggregates

    Abstract

    In the present study, methotrexate (MTX)-degrading 36-kDa dimer was characterized from the 0–80% ammonium sulphate precipitate of Variovorax...

    C. K. Sahu, V. K. Bayineni, ... R.-K. Kadeppagari in Applied Biochemistry and Microbiology
    Article 12 August 2023
  7. Evaluation by different mechanisms of the protective effects of vitamin B12 on methotrexate nephrotoxicity

    Methotrexate is used for cure of many cancer types. It has many side effects. For this reason, obtaining a nephroprotective agent is obligatory. In...

    E. Ozturk, D. Karabulut, ... B. Yakan in Journal of Molecular Histology
    Article 16 October 2021
  8. Evaluation of the antiapoptotic and anti-inflammatory properties of chitosan in methotrexate-induced oral mucositis in rats

    Background

    Methotrexate (MTX), a chemotherapeutic agent, is known to cause oral mucositis. Chitosan has been shown to have a protective effect in...

    Kani Bilginaylar, Asli Aykac, ... Ahmet Özer Şehirli in Molecular Biology Reports
    Article 21 January 2022
  9. Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase

    Metformin, the first-line drug for type II diabetes, has recently been considered an anticancer agent. However, the molecular target and underlying...

    Yinghui Wang, Hui Lu, ... ** Gao in Cell Death & Disease
    Article Open access 02 October 2021
  10. The impact of Nrf2/HO-1, caspase-3/Bax/Bcl2 and ATF6/IRE1/PERK/GRP78 signaling pathways in the ameliorative effects of morin against methotrexate-induced testicular toxicity in rats

    Background

    Methotrexate (MT) is a broadly used chemotherapeutic drug however its clinical use is confronted with several forms of toxicities...

    Behçet Varışlı, Cuneyt Caglayan, ... Aydın Genç in Molecular Biology Reports
    Article 03 September 2022
  11. The Effect of Methotrexate on Serum Levels of Trace/Mineral Elements in Patients with Psoriatic Arthritis

    Psoriatic arthritis is a type of inflammatory arthritis that occurs in some patients with psoriasis. Clinically, low-dose methotrexate was used to...

    Yue Gao, **a Li, ... Zheng Liu in Biological Trace Element Research
    Article 15 January 2021
  12. Molecular mechanism of action and pharmacokinetic properties of methotrexate

    Since its discovery in 1945, methotrexate has become a standard therapy for number of diseases, including oncological, inflammatory and pulmonary...

    V. Maksimovic, Z. Pavlovic-Popovic, ... S. Golocorbin-Kon in Molecular Biology Reports
    Article 15 May 2020
  13. Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy

    Methotrexate (MTX) is one of the most commonly prescribed drugs for autoimmune rheumatic diseases. As there is no consensus on its negative effects...

    Tim Rolvien, Nico Maximilian Jandl, ... Michael Amling in Calcified Tissue International
    Article Open access 16 October 2020
  14. Alterations in the matrix metalloproteinase-3 promoter methylation after common chemotherapeutics: in vitro study of paclitaxel, cisplatin and methotrexate in the MCF-7 and SH-SY5Y cell lines

    Cancer treatment is a complex process due to the several encountered obstacles during therapy, such as metastasis, angiogenesis, and drug resistance....

    Zulfinaz Betul Celik, Fatma Nihan Cankara, Caner Gunaydin in Molecular Biology Reports
    Article 02 November 2020
  15. Designing a novel drug–drug conjugate as a prodrug for breast cancer therapy: in silico insights

    Breast cancer (BC) poses a significant global health threat, necessitating innovative therapeutic approaches. The ribosomal s6 kinase 2 (RSK2) has...

    Sankar Muthumanickam, Balajee Ramachandran, ... Boomi Pandi in Molecular Diversity
    Article 04 June 2024
  16. Clinical Manifestations and Prognosis of Giant Cell Arteritis: A Retrospective Cohort Study

    Abstract

    The aim of the study was to evaluate the clinical manifestations and survival of patients with giant cell arteritis (GCA).

    Materials and...
    E. E. Fedorinova, N. M. Bulanov, ... S. V. Moiseev in Doklady Biochemistry and Biophysics
    Article 13 July 2024
  17. Methotrexate impaired in-vivo matured mouse oocyte quality and the possible mechanisms

    Background

    Methotrexate (MTX) is an antifolate agent which is widely used in clinic for treating malignancies, rheumatoid arthritis and ectopic...

    Ning Tian, Dan-yu Lv, ... Wan-yun Ma in BMC Molecular and Cell Biology
    Article Open access 03 July 2020
  18. Whey-based diet containing medium chain triglycerides modulates the gut microbiota and protects the intestinal mucosa from chemotherapy while maintaining therapy efficacy

    Cytotoxicity (i.e. cell death) is the core mechanism by which chemotherapy induces its anti-cancer effects. Unfortunately, this same mechanism...

    Hannah R. Wardill, Ana Rita Da Silva Ferreira, ... Wim J. E. Tissing in Cell Death & Disease
    Article Open access 23 May 2023
  19. Design, Synthesis, Computational, and In Vitro Cytotoxic Potential of Novel 5,7,8,9-Tetrahydrotetrazolo[5,1-b]quinazolines Analogs

    Abstract

    Objective: Quinazolines and condensed quinazolines got a significant role to be treated as the pharmacophore nucleus for various diseases by...

    Asief Mohammed, Shiva Kumar Gubbiyappa, Rajasekhar Reddy Alavala in Russian Journal of Bioorganic Chemistry
    Article 09 April 2024
Did you find what you were looking for? Share feedback.